These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 8001682
1. Susceptibility of phospholipids of oxidizing LDL to enzymatic hydrolysis modulates uptake by P388D1 macrophage-like cells. Fyrnys B, Blencowe C, Deigner HP. FEBS Lett; 1995 Jan 02; 357(1):7-12. PubMed ID: 8001682 [Abstract] [Full Text] [Related]
3. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. Tsoukatos DC, Arborati M, Liapikos T, Clay KL, Murphy RC, Chapman MJ, Ninio E. Arterioscler Thromb Vasc Biol; 1997 Dec 02; 17(12):3505-12. PubMed ID: 9437199 [Abstract] [Full Text] [Related]
4. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, Du BN, Fogelman AM, Berliner JA. J Clin Invest; 1995 Feb 02; 95(2):774-82. PubMed ID: 7860760 [Abstract] [Full Text] [Related]
5. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro. Schnitzer E, Pinchuk I, Fainaru M, Lichtenberg D, Yedgar S. Free Radic Biol Med; 1998 May 02; 24(7-8):1294-303. PubMed ID: 9626586 [Abstract] [Full Text] [Related]
6. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM. J Biol Chem; 1989 Apr 05; 264(10):5331-4. PubMed ID: 2494162 [Abstract] [Full Text] [Related]
7. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. Kramer RM, Jakubowski JA, Deykin D. Biochim Biophys Acta; 1988 Apr 15; 959(3):269-79. PubMed ID: 3355850 [Abstract] [Full Text] [Related]
8. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Liapikos TA, Antonopoulou S, Karabina SP, Tsoukatos DC, Demopoulos CA, Tselepis AD. Biochim Biophys Acta; 1994 Jun 02; 1212(3):353-60. PubMed ID: 8199206 [Abstract] [Full Text] [Related]
9. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. Steinbrecher UP, Pritchard PH. J Lipid Res; 1989 Mar 02; 30(3):305-15. PubMed ID: 2723538 [Abstract] [Full Text] [Related]
10. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein. Tsoukatos DC, Liapikos TA, Tselepis AD, Chapman MJ, Ninio E. Biochem J; 2001 Jul 15; 357(Pt 2):457-64. PubMed ID: 11439095 [Abstract] [Full Text] [Related]
11. PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation. Dentan C, Lesnik P, Chapman MJ, Ninio E. Arterioscler Thromb; 1994 Mar 15; 14(3):353-60. PubMed ID: 8123638 [Abstract] [Full Text] [Related]
13. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. Androulakis N, Durand H, Ninio E, Tsoukatos DC. J Lipid Res; 2005 Sep 15; 46(9):1923-32. PubMed ID: 15995176 [Abstract] [Full Text] [Related]
14. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. Subramanian VS, Goyal J, Miwa M, Sugatami J, Akiyama M, Liu M, Subbaiah PV. Biochim Biophys Acta; 1999 Jul 09; 1439(1):95-109. PubMed ID: 10395969 [Abstract] [Full Text] [Related]
15. Purification and characterization of platelet-activating factor acetylhydrolase from peritoneal fluid obtained from guinea pigs after endotoxin shock. Karasawa K, Yato M, Setaka M, Nojima S. J Biochem; 1994 Aug 09; 116(2):374-9. PubMed ID: 7822257 [Abstract] [Full Text] [Related]
16. Inflammatory platelet-activating factor-like phospholipids in oxidized low density lipoproteins are fragmented alkyl phosphatidylcholines. Marathe GK, Davies SS, Harrison KA, Silva AR, Murphy RC, Castro-Faria-Neto H, Prescott SM, Zimmerman GA, McIntyre TM. J Biol Chem; 1999 Oct 01; 274(40):28395-404. PubMed ID: 10497200 [Abstract] [Full Text] [Related]
17. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties. Stafforini DM, Rollins EN, Prescott SM, McIntyre TM. J Biol Chem; 1993 Feb 25; 268(6):3857-65. PubMed ID: 8440681 [Abstract] [Full Text] [Related]
18. Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. McCall MR, La Belle M, Forte TM, Krauss RM, Takanami Y, Tribble DL. Biochim Biophys Acta; 1999 Jan 29; 1437(1):23-36. PubMed ID: 9931415 [Abstract] [Full Text] [Related]
19. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. Herrmann DB, Ferber E, Munder PG. Biochim Biophys Acta; 1986 Mar 21; 876(1):28-35. PubMed ID: 3947667 [Abstract] [Full Text] [Related]
20. Identification of a membrane-associated 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine hydrolyzing phospholipase A2 in guinea pig 1 epidermis. Implications in the cutaneous biosynthesis of platelet-activating factor. Wong B, Tang W, Ziboh VA. FEBS Lett; 1992 Jul 06; 305(3):213-6. PubMed ID: 1299618 [Abstract] [Full Text] [Related] Page: [Next] [New Search]